Table 2: biochemical and thyroid hormones levels of the studied population

Parameter

CKD patients

(N = 60)

Control

(N = 65)

95% CI

of mean diff

p-value

Serum Creat. (mmol/L)

189.84 ± 111.42

78.06 ± 20.59

83.81 - 139.73

< 0.001*

Creat. Clear. (ml/min)

55.33 ± 38.29

107.12 ± 43.54

- 67.29 - (-36.27)

< 0.001*

GFR (ml/min/1.73m2)

63.83 ± 46.63

132.78 ± 35.09

- 84.12 - (-53.80 )

< 0.001*

TC (mmol/l)

TG (mmol/l)

4.74 ± 1.78

1.60 ± 0.88

4.98 ± 1.09

1.09 ± .72

-0.77 - 0.30

0.22 - 0.79

0.001*

0.001*

HDL-c (mmol/l)

1.19 ± 0.22

1.14 ± 0.19

-0.02 - 0.13

0.158

LDL-c (mmol/l)

3.12 ± 2.33

3.3 ± 0.84

-0.84 - 0.39

0.471

VLDL-c (mmol/l)

0.74 ± 0.50

0.50 ± 0.33

0.10 - 0.37

0.001*

TSH (mIU/ml)

1.87 ± 1.51

2.36 ± 1.31

-1.02 - 0.03

0.064

FT3 (pmol/L)

4.83 ± 2.72

3.43 ± 0.70

0.70 - 2.09

< 0.001*

FT4 (pmol/L)

14.32 ± 2.91

10.80 ± 2.71

2.47 - 4.57

< 0.001*

N = Sample size, CI = Confidence Interval, CKD = Chronic Kidney Disease, Serum Creat = Serum Creatinine, Creat. Clear. = Creatinine Clearance, GFR = Glomerular Filtration Rate, TC = Total Cholesterol, TG = Triglyceride, HDL-c = High Density Lipoprotein cholesterol, LDL-c = Low Density Lipoprotein cholesterol, VLDL-c = Very Low Density Lipoprotein cholesterol, TSH = Thyroid stimulating hormone, FT3 = Free triiodothyronine, FT4 = Thyroxine   Result is presented as mean ± standard deviation. *P-values less than 0.05 were considered statistically significant.